7
CDCl3): δ 221.6, 141.7, 120.8, 72.7, 66.7, 57.6, 51.0, 50.9, 47.6,
43.5, 42.8, 37.6, 37.2, 37.1, 35.2, 33.8, 32.8, 32.2, 30.1, 26.1,
25.1, 21.0, 20.0, 19.5, 18.4, 17.9, −4.4 IR (cm–1): 2930, 2857,
1733, 1462, 1383, 1251, 1088, 870, 834, 773, 737, 666, 617 GC-
MS (m/z): [M] calc’d for C30H50O2Si: 470.4; found: 469.4.
3.78 (m, 4H), 2.27–2.18 (m, 4H), 1.91–1.79 (m, 3H), 1.72–1.61
(m, 3H), 1.59–1.38 (m, 4H), 1.12–1.01 (m, 1H), 0.98 (d, J = 6.4
Hz, 3H) 13C NMR (101 MHz, CDCl3): δ 212.6, 110.9, 65.6, 64.3,
56.8, 48.0, 34.8, 33.4, 32.1, 31.0, 29.0, 23.5, 22.3, 21.5 IR (cm–
1): 2929, 2869, 1707, 1450, 1298, 1182, 1102, 1085, 1032, 954,
859, 565 GC-MS (m/z): [M] calc’d for C14H22O3: 238.2; found:
238.2.
4.6.9.
8(1H)-one (2i)
Compound 2i was prepared from 1i (40.0 mg, 0.20 mmol, 1.0
1,3a-dimethyl-2,3,3a,8a-tetrahydrocyclopenta[a]inden-
4.6.12. ethyl-1,4-dimethyl-2-oxocyclohexane-1-carboxylate (2l)
Compound 2l was prepared from 1l (39.7 mg, 0.20 mmol, 1.0
equiv) according to the general procedure (2 hours). Purification
by flash column chromatography on silica gel (10%
Et2O/hexanes) afforded 2l (17.0 mg, 43%) as a colorless oil. Rf:
equiv) according to the general procedure (2 hours). Purification
by flash column chromatography on silica gel (4% Et2O/hexanes)
afforded 2i (30.3 mg, 76%, dr = 1.2:1) as an orange oil. Rf: 0.35
1
(10% Et2O/hexanes) H NMR (500 MHz, CDCl3): δ 7.65 (dd, J
1
0.41 (20% Et2O/hexanes) H NMR (400 MHz, CDCl3): δ 4.19
= 7.5, 3.5 Hz, 1H), 7.63–7.59 (m, 1H), 7.47 (d, J = 7.5 Hz, 1H),
7.36–7.33 (m, 1H), 2.55 (d, J = 10.0 Hz, 0.45H), 2.45–2.35 (m,
0.45H), 2.30–2.27 (m, 0.55 H), 2.06–1.98 (m, 1H), 1.86 (ddd, J =
12.5, 6.5, 5.5 Hz, 0.45H), 1.77 (atd, J = 13.0, 6.0 Hz, 0.55H),
1.69 (adt, J = 12.0, 6.0 Hz, 0.55H), 1.61–1.57 (m, 1H), 1.53 (s,
1.35H), 1.49–1.43 (m, 0.45H), 1.47 (s, 1.65H), 1.22 (d, J = 7.0
Hz, 1.35H), 1.09 (d, J = 7.0 Hz, 1.65H), 0.93 (ddd, J = 24.5,
12.0, 5.5 Hz, 0.55H) 13C NMR (151 MHz, CDCl3): δ 209.1,
208.0, 163.1, 163.0, 137.8, 135.7, 135.5, 135.2, 127.5, 127.5,
124.3, 124.0, 123.5, 122.7, 68.0, 62.9, 51.8, 51.1, 40.7, 39.6,
39.1, 38.7, 34.6, 34.6, 28.5, 27.8, 21.1, 16.1 IR (cm–1): 2954,
2925, 2857, 1709, 1603, 1462, 1285, 764 GC-MS (m/z): [M]
calc’d for C14H16O: 200.1; found: 200.1.
(q, J = 7.0 Hz, 2H), 2.57–2.51 (m, 1H), 2.39 (ddd, J = 13.6, 7.2,
4.0 Hz, 1H), 2.25–2.15 (m, 2H), 1.92–1.84 (m, 1H), 1.73 (ddd, J
= 13.6, 9.2, 4.0 Hz, 1H), 1.52–1.43 (m, 1H), 1.34 (s, 3H), 1.26
(at, J = 7.2 Hz, 3H), 0.98 (d, J = 6.4 Hz, 3H) 13C NMR (101
MHz, CDCl3): δ 208.9, 173.3, 61.4, 57.0, 46.8, 33.8, 32.8, 28.9,
20.9, 20.2, 14.2 IR (cm–1): 2935, 2871, 1735, 1712, 1456, 1377,
1258, 1090, 1026, 860 GC-MS (m/z): [M] calc’d for C11H18O3:
198.1; found: 198.2.
4.6.13. ethyl 1-allyl-4-methyl-2-oxocyclohexane-1-carboxylate
(2m)
Compound 2m was prepared from 1m (44.9 mg, 0.20 mmol,
1.0 equiv) according to the general procedure (6 hours).
Purification by flash column chromatography on silica gel (4%
Et2O/hexanes) afforded diastereomers 2ma (6.5 mg, 14%) and
2mb (17.5 mg, 39%) as a colorless oil. 2ma: Rf: 0.51 (20%
4.6.10. 9-methyl-1,4-dioxadispiro[4.0.56.35]tetradecan-7-one (2j)
Compound 2j was prepared from 1j (44.9 mg, 0.20 mmol, 1.0
equiv) according to the general procedure (6 hours). Purification
by flash column chromatography on silica gel (10%
Et2O/hexanes) afforded diastereomers 2ja (12.1 mg, 27%) and
2jb (11.6 mg, 26%) as colorless oils. 2ja: Rf: 0.35 (20%
1
Et2O/hexanes) H NMR (400 MHz, CDCl3): δ 5.79–5.68 (m,
1H), 5.12–4.95 (m, 2H), 4.17 (q, J = 7.2 Hz, 2H), 2.60 (dd, J =
14.0, 7.2 Hz, 1H), 2.49–2.39 (m, 2H), 2.29 (dd, J = 14.0, 8.0 Hz,
1H), 2.18–2.11 (m, 1H), 1.85–1.70 (m, 2H), 1.45–1.34 (m, 2H),
1.24 (t, J = 7.2 Hz, 3H), 0.99 (d, J = 6.4 Hz, 3H) 13C NMR (101
MHz, CDCl3): δ 207.1, 171.5, 133.5, 118.4, 61.4, 59.9, 49.5,
39.4, 35.4, 34.9, 31.4, 22.4, 14.3 IR (cm–1): 2956, 2929, 1713,
1439, 1222, 1196, 1143, 1093, 1027, 918, 608 GC-MS (m/z):
[M] calc’d for C13H20O3: 224.1; found: 224.2 2mb: Rf: 0.61 (20%
1
Et2O/hexanes) H NMR (400 MHz, CDCl3): δ 3.99–3.85 (m,
4H), 2.47–2.27 (m, 4H), 1.84–1.63 (m, 4H), 1.62–1.50 (m, 3H),
1.40 (atd, J = 12.8, 5.2 Hz, 1H), 1.27–1.20 (m, 1H), 0.98 (d, J =
6.4 Hz, 3H) 13C NMR (101 MHz, CDCl3): δ 212.4, 118.1, 64.5,
64.3, 58.1, 50.2, 35.0, 34.5, 34.4, 33.7, 31.2, 22.7, 19.2 IR (cm–
1): 2952, 2874, 1698, 1456, 1442, 1309, 1213, 1152, 1126, 1063,
1016, 945, 931, 584, 528, 473 GC-MS (m/z): [M] calc’d for
C13H20O3: 224.1; found: 224.2 2jb: Rf: 0.22 (20% Et2O/hexanes)
1H NMR (400 MHz, CDCl3): δ 3.97–3.88 (m, 4H), 2.51 (ddd, J
= 14.0, 4.8, 0.4 Hz, 1H), 2.22–2.13 (m, 2H), 2.09–1.93 (m, 3H),
1.90–1.72 (m, 3H), 1.66–1.51 (m, 3H), 1.36–1.27 (m, 1H), 0.96
(d, J = 6.8 Hz, 3H) 13C NMR (101 MHz, CDCl3): δ 212.1, 118.3,
65.4, 64.1, 59.9, 47.9, 34.4, 34.1, 32.8, 30.5, 29.9, 21.1, 18.9 IR
(cm–1): 2952, 2874, 1698, 1456, 1442, 1309, 1213, 1152, 1126,
1063, 1016, 945, 931, 584, 528, 473 GC-MS (m/z): [M] calc’d
for C13H20O3: 224.1; found: 224.2.
1
Et2O/hexanes) H NMR (400 MHz, CDCl3): δ 5.78–5.67 (m,
1H), 5.08–5.04 (m, 2H), 4.18 (q, J = 7.2 Hz, 2H), 2.62 (dd, J =
14.0, 6.8 Hz, 1H), 2.55 (dd, J = 13.6, 4.4 Hz, 1H), 2.40 (dd, J =
14.0, 7.6 Hz, 1H), 2.31 (ddd, J = 13.6, 6.4, 4.0 Hz, 1H), 2.26–
2.13 (m, 2H), 1.93–1.85 (m, 1H), 1.77 (ddd, J = 13.6, 10.0, 4.0
Hz, 1H), 1.52–1.44 (m, 1H), 1.25 (t, J = 7.2 Hz, 3H), 0.96 (d, J =
6.4 Hz, 3H) 13C NMR (101 MHz, CDCl3): δ 207.8, 171.7, 133.3,
118.6, 61.3, 60.7, 47.4, 38.5, 32.6, 30.7, 28.5, 19.9, 14.3 IR (cm–
1): 2956, 2929, 1713, 1439, 1222, 1196, 1143, 1093, 1027, 918,
608 GC-MS (m/z): [M] calc’d for C13H20O3: 224.1; found: 224.2.
4.6.14. 1-allyl-4-methyl-2-oxabicyclo[3.3.1]nonan-6-one (2n)
Compound 2n was prepared from 1n (38.9 mg, 0.20 mmol,
1.0 equiv) according to the general procedure (4 hours).
Purification by flash column chromatography on silica gel (8%
Et2O/hexanes) afforded 2n (15.9 mg, 41%) as a colorless oil. Rf:
4.6.11. 9-methyl-1,4-dioxadispiro[4.0.56.45]pentadecan-7-one
(2k)
Compound 2k was prepared from 1k (47.7 mg, 0.20 mmol,
1.0 equiv) according to the general procedure (6 hours).
Purification by flash column chromatography on silica gel (20%
Et2O/hexanes) afforded diastereomers 2ka (13.7 mg, 29%) and
2kb (20.5 mg, 43%) as a colorless oil. 2ka: Rf: 0.32 (20%
1
0.52 (40% Et2O/hexanes) H NMR (500 MHz, CDCl3): δ 5.87
(ddt, J = 17.5, 10.5, 7.5 Hz, 1H), 5.13–5.07 (m, 2H), 3.81 (dd, J =
12.5, 5.5 Hz, 1H), 3.55 (at, J = 12.5 Hz, 1H), 2.57–2.51 (m, 2H),
2.46–2.38 (m, 1H), 2.26 (d, J = 7.5 Hz, 2H), 2.14–2.03 (m, 2H),
2.00–1.93 (m, 1H), 1.91–1.87 (m, 2H), 0.81 (d, J = 6.5 Hz, 3H)
13C NMR (151 MHz, CDCl3): δ 213.3, 133.6, 118.4, 70.9, 68.0,
49.2, 47.1, 39.1, 36.2, 33.5, 32.1, 14.9 IR (cm–1): 2926, 1703,
1440, 1104, 1078, 990, 963, 915, 853, 640, 413 GC-MS (m/z):
[M] calc’d for C12H18O2: 194.1; found: 194.2.
1
Et2O/hexanes) H NMR (400 MHz, CDCl3): δ 3.97–3.86 (m,
4H), 2.43 (dd, J = 13.2, 4.8 Hz, 1H), 2.36–2.29 (m, 2H), 2.18–
2.11 (m, 1H), 2.00–1.88 (m, 1H), 1.76–1.63 (m, 4H), 1.56–1.47
(m, 3H), 1.44–1.31 (m, 3H), 0.98 (d, J = 6.8 Hz, 3H) 13C NMR
(101 MHz, CDCl3): δ 213.8, 111.5, 64.4, 64.3, 55.0, 49.7, 34.0,
33.9, 32.7, 31.5, 29.5, 23.2, 21.7, 20.9 IR (cm–1): 2929, 2869,
1707, 1450, 1298, 1182, 1102, 1085, 1032, 954, 859, 565 GC-
MS (m/z): [M] calc’d for C14H22O3: 238.2; found: 238.2 2kb: Rf:
4.6.15. 5,8-dimethylbicyclo[3.3.1]non-3-en-2-one (2o)
1
0.21 (20% Et2O/hexanes) H NMR (400 MHz, CDCl3): δ 4.03–